-
Novo Nordisk to cap insulin prices in Minnesota settlement
The settlement filed in a New Jersey federal court follows similar settlements last year with Eli Lilly and French drugmaker Sanofi.
-
AstraZeneca faces US class action lawsuit amidst China regulatory probes
The lawsuit claims that UK’s largest listed company misled shareholders in connection with investigations by the Chinese government.
-
Is the new EU Health Data Space Regulation a turning point for EU health data access?
The regulation creates an EU health “data space” and is designed to facilitate access to and control of health data.
-
FDA updates guide on comms about unapproved use of approved medical products
Final guidance clarifies FDA approach and addresses issues the industry raised regarding a draft version.
-
GRIP Extra: Wise ordered to pay $2.5m CFPB fine, FTC Chairman says “DEI is over”
Other news includes the CFPB mulling moves to prevent debanking, cybercrime websites being seized by EU authorities, and Blackstone staying the course on data center investment.
-
Pfizer and Novo Nordisk rebuked over pharma payments
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
-
QOL Medical and CEO fined $47m for kickback scheme
The company overstated diagnostic claims to boost sales of its flagship product Sucraid.
-
Boston Consulting report pinpoints businesses adding value with AI
Global study finds leading adopters generating revenue growth that is 50% above average and reshaping core processes.